New Frontiers: Research Advances for High-Risk and Advanced Prostate Cancer

Beyond imaging and genetic testing, several distinct lines of research reported in 2026 are reshaping how doctors think about high-risk […]

Two New Approvals, One Clear Direction — Targeted Drug Therapies Come of Age in 2025

The past year brought two significant FDA approvals that signal where prostate cancer treatment is heading: toward more precise, earlier-acting […]

“Smart” Radiation Gets Smarter — Lutetium-177 Therapy Expands Its Reach

A treatment once reserved for men who had exhausted nearly every other option is now available earlier in the course […]